Related references
Note: Only part of the references are listed.Microbiome therapeutics: exploring the present scenario and challenges
Monika Yadav et al.
GASTROENTEROLOGY REPORT (2022)
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria
David Lubkowicz et al.
MOLECULAR SYSTEMS BIOLOGY (2022)
A programmable encapsulation system improves delivery of therapeutic bacteria in mice
Tetsuhiro Harimoto et al.
CURRENT SCIENCE (2022)
Enhancing the tropism of bacteria via genetically programmed biosensors
Tiffany Chien et al.
NATURE BIOMEDICAL ENGINEERING (2022)
Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS
Longsha Liu et al.
EBIOMEDICINE (2022)
An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis
Andres Cubillos-Ruiz et al.
NATURE BIOMEDICAL ENGINEERING (2022)
Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes
Baylee J. Russell et al.
CELL (2022)
Engineered Bacteria-Based Living Materials for Biotherapeutic Applications
Rabia Omer et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Development of synthetic biotics as treatment for human diseases
Aoife M. Brennan
SYNTHETIC BIOLOGY (2022)
Pathophysiology and Treatment of Enteric Hyperoxaluria
Celeste Witting et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
Mark R. Charbonneau et al.
COMMUNICATIONS BIOLOGY (2021)
The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study
Chin-Song Lu et al.
FRONTIERS IN NUTRITION (2021)
The gut microbiota-brain axis in behaviour and brain disorders
Livia H. Morais et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues
Mirae Lee et al.
GASTROENTEROLOGY (2021)
Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood
Adi Eindor-Abarbanel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Engineering living therapeutics with synthetic biology
Andres Cubillos-Ruiz et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering
Kristin J. Adolfsen et al.
NATURE COMMUNICATIONS (2021)
Recent Development of Probiotic Bifidobacteria for Treating Human Diseases
Jun Chen et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
Single strain control of microbial consortia
Alex J. H. Fedorec et al.
NATURE COMMUNICATIONS (2021)
Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip
M. Tyler Nelson et al.
NATURE COMMUNICATIONS (2021)
Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol
Helen Tang et al.
BMJ OPEN (2021)
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer
Tatiana Galicia-Carmona et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial
Eric Climent et al.
MICROORGANISMS (2021)
Engineered acetoacetate-inducible whole-cell biosensors based on the AtoSC two-component system
Jack W. Rutter et al.
BIOTECHNOLOGY AND BIOENGINEERING (2021)
Theranostic cells: emerging clinical applications of synthetic biology
Monica P. McNerney et al.
NATURE REVIEWS GENETICS (2021)
Engineered living biomaterials
Aleixandre Rodrigo-Navarro et al.
NATURE REVIEWS MATERIALS (2021)
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study
Marja K. Puurunen et al.
NATURE METABOLISM (2021)
The gut microbiota in osteoarthritis: where do we stand and what can we do?
Xiaoxia Hao et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Synthetic Biology Enables Programmable Cell-Based Biosensors
Maggie Hicks et al.
CHEMPHYSCHEM (2020)
Editing the microbiome
Jyoti Madhusoodanan
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung et al.
EBIOMEDICINE (2020)
How Probiotics Affect the Microbiota
Gregoire Wieers et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Predictable modulation of cancer treatment outcomes by the gut microbiota
Yoshitaro Heshiki et al.
MICROBIOME (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal et al.
NATURE COMMUNICATIONS (2020)
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Mark R. Charbonneau et al.
NATURE COMMUNICATIONS (2020)
Engineered Live Biotherapeutics: Progress and Challenges
Yang Tan et al.
BIOTECHNOLOGY JOURNAL (2020)
Global analysis of clinical trials with probiotics
Theresia M. G. Dronkers et al.
HELIYON (2020)
Host-microbiota interactions in inflammatory bowel disease
Roberta Caruso et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The microbiome, cancer, and cancer therapy
Beth A. Helmink et al.
NATURE MEDICINE (2019)
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Sreyan Chowdhury et al.
NATURE MEDICINE (2019)
Common principles and best practices for engineering microbiomes
Christopher E. Lawson et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Detecting Changes in the Caenorhabditis elegans Intestinal Environment Using an Engineered Bacterial Biosensor
Jack W. Rutter et al.
ACS SYNTHETIC BIOLOGY (2019)
Bacteria-cancer interactions: bacteria-based cancer therapy
Mai Thi-Quynh Duong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
An engineered E-coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
Caroline B. Kurtz et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy
Christian Ronquillo Pangilinan et al.
BIOMEDICINES (2019)
Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
Zachary T. Morrow et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2019)
Engineering bacteria for diagnostic and therapeutic applications
David T. Riglar et al.
NATURE REVIEWS MICROBIOLOGY (2018)
The human skin microbiome
Allyson L. Byrd et al.
NATURE REVIEWS MICROBIOLOGY (2018)
An ingestible bacterial-electronic system to monitor gastrointestinal health
Mark Mimee et al.
SCIENCE (2018)
Microbiome and Allergic Diseases
Mariona Pascal et al.
FRONTIERS IN IMMUNOLOGY (2018)
Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features
Niv Zmora et al.
CELL (2018)
VXM01 phase I study in patients with progressive glioblastoma: Final results.
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Probiotics in Disease Prevention and Treatment
Yuying Liu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Vincent M. Isabella et al.
NATURE BIOTECHNOLOGY (2018)
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease
J. Scott Crowe et al.
SCIENTIFIC REPORTS (2018)
Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity
Tanel Ozdemir et al.
CELL SYSTEMS (2018)
The oral microbiota: dynamic communities and host interactions
Richard J. Lamont et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress
John C. Flickinger et al.
VACCINES (2018)
Microfluidic Organ-on-a-Chip Models of Human Intestine
Amir Bein et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
A randomized synbiotic trial to prevent sepsis among infants in rural India
Pinaki Panigrahi et al.
NATURE (2017)
Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation
David T. Riglar et al.
NATURE BIOTECHNOLOGY (2017)
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
In Young Hwang et al.
NATURE COMMUNICATIONS (2017)
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
Clement T. Y. Chan et al.
NATURE CHEMICAL BIOLOGY (2016)
Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001
Joseph J. Sacco et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Fecal microbiota transplantation: in perspective
Shaan Gupta et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Personalized Nutrition by Prediction of Glycemic Responses
David Zeevi et al.
CELL (2015)
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer
Andreas G. Niethammer et al.
BMC CANCER (2012)
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer
Raquibul Hannan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human
V. Shahabi et al.
CANCER GENE THERAPY (2011)
Attenuated Listeria monocytogenes vaccine vectors expressing Influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers
Paul V. Johnson et al.
MICROBIOLOGY AND IMMUNOLOGY (2011)
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
K. Vandenbroucke et al.
MUCOSAL IMMUNOLOGY (2010)
AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis
Silvia Caluwaerts et al.
ORAL ONCOLOGY (2010)
Responders and non-responders to probiotic interventions How can we improve the odds?
Gregor Reid et al.
GUT MICROBES (2010)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)